Strides Arcolab reports 93% fall in Q3 net profit

14 Nov 2013 Evaluate

Strides Arcolab has reported results for the third quarter ended September 30, 2013.

The company has reported 92.66% fall in its net profit at Rs 2.21 crore for the quarter as compared to Rs 30.11 crore for the same quarter in the previous year. However, total income of the company has increased by 13.59% at Rs 225.46 crore for quarter under review as compared to Rs 198.48 crore for the quarter ended September 30, 2012.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

874.00 10.50 (1.22%)
10-Mar-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1315.70
Cipla 1333.10
Zydus Lifesciences 923.95
Lupin 2344.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×